{"id":500651,"date":"2021-06-03T16:13:23","date_gmt":"2021-06-03T20:13:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\/"},"modified":"2021-06-03T16:13:23","modified_gmt":"2021-06-03T20:13:23","slug":"zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\/","title":{"rendered":"Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>\n        <strong>C<\/strong><br \/>\n        <strong>ompany <\/strong><br \/>\n        <strong>a<\/strong><br \/>\n        <strong>nnouncement \u2013 No. 36<\/strong><br \/>\n        <strong>\/ 202<\/strong><br \/>\n        <strong>1<\/strong>\n      <\/p>\n<p>\n        <strong>Zealand Pharma to <\/strong><br \/>\n        <strong>P<\/strong><br \/>\n        <strong>articipate in <\/strong><br \/>\n        <strong>Goldman Sachs 42<\/strong><br \/>\n        <sup><br \/>\n          <strong>nd<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Global Healthcare Conference<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <em>Copenhagen, DK and Boston, MA, U.S. <\/em><br \/>\n        <em>June 3<\/em><br \/>\n        <em>, 2021 \u2013 <\/em>Zealand Pharma A\/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, today announced that members of its senior management team are scheduled to participate virtually in the Goldman Sachs 42nd Annual Global Healthcare Conference:<\/p>\n<p>\n        <strong>Goldman Sachs 42nd Annual Global Healthcare Conference<\/strong>\n      <\/p>\n<p>Date: Thursday, June 10, 2021<\/p>\n<p>Presentation: 9:40 a.m. ET \/ 3:40 p.m. CET<\/p>\n<p>A live webcast of the event will be available on the &#8220;Events &amp; Presentations&#8221; page in the Investor section of the Company&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=460iyl72-w2Yws5hAB57Jj4xfrgRXbAquKr07ZP4vP5mHX4cj--QDiVrDmFSWFV113BUgsgjmZheh0b4qA7cHTiQJ5hghG5UeIaUP7WA38ZWyoliu-P4Qr7-06dHOvXxIu23IFc2oRn0Y9Iqtj-Y2ckYtYMYmFS6fWWSsGjagQI=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.zealandpharma.com\/events-presentations<\/a>. A replay of the webcast will be archived on the Company&#8217;s website following the presentation.<\/p>\n<p align=\"center\">\n        <strong># # #<\/strong>\n      <\/p>\n<p>\n        <strong>About Zealand Pharma A\/S <\/strong><br \/>\n        <br \/>Zealand Pharma A\/S (Nasdaq: ZEAL) (&#8220;Zealand&#8221;) is a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market. Zealand\u2019s robust pipeline of investigational medicines includes three candidates in late stage development. Zealand markets V-Go\u00ae, abasal-bolus insulin delivery option for people with diabetes and has received approval for Zegalogue\u00ae (dasiglucagon), the first and only glucagon analogue for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 6 and above. License collaborations with Boehringer Ingelheim and Alexion Pharmaceuticals create opportunity for more patients to potentially benefit from Zealand-invented peptide therapeutics. Zealand was founded in 1998 in Copenhagen, Denmark, and has presence throughout the U.S. that includes key locations in New York, Boston, and Marlborough (MA). For more information about Zealand\u2019s business and activities, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=j2RoYarOPJQSvG06okMP2mtD8opG5H153rcnUeeCGFi6XoV12BKKsmBwau0auuw618ZiatxrvUUDljsS2hAqZyaX601yBRXjpbEUEWVxsRI=\" rel=\"nofollow noopener\" target=\"_blank\">www.zealandpharma.com<\/a>.<\/p>\n<p>\n        <strong>For further information, please contact:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;border-collapse:collapse\">\n<tr>\n<td>\n            <strong>Zealand Pharma Investor Relations<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td>Claudia Styslinger<\/td>\n<\/tr>\n<tr>\n<td>Argot Partners<\/td>\n<\/tr>\n<tr>\n<td>investors@zealandpharma.com<\/td>\n<\/tr>\n<\/table>\n<p>\u00a0<\/p>\n<table style=\"border-collapse: collapse;border-collapse:collapse\">\n<tr>\n<td>\n            <strong>Zealand Pharma Media Relations<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td>David Rosen<\/td>\n<\/tr>\n<tr>\n<td>Argot Partners<\/td>\n<\/tr>\n<tr>\n<td>media@zealandpharma.com<\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUwODY0MSM0MDA5NjA3MTMjMjAwMTcwMQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml-eu.globenewswire.com\/release\/track\/ec3415e3-81d8-49ac-b793-539aff494b42\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>C ompany a nnouncement \u2013 No. 36 \/ 202 1 Zealand Pharma to P articipate in Goldman Sachs 42 nd Annual Global Healthcare Conference Copenhagen, DK and Boston, MA, U.S. June 3 , 2021 \u2013 Zealand Pharma A\/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, today announced that members of its senior management team are scheduled to participate virtually in the Goldman Sachs 42nd Annual Global Healthcare Conference: Goldman Sachs 42nd Annual Global Healthcare Conference Date: Thursday, June 10, 2021 Presentation: 9:40 a.m. ET \/ 3:40 p.m. CET A live webcast of the event will be available on the &#8220;Events &amp; Presentations&#8221; page in the Investor section of the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-500651","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"C ompany a nnouncement \u2013 No. 36 \/ 202 1 Zealand Pharma to P articipate in Goldman Sachs 42 nd Annual Global Healthcare Conference Copenhagen, DK and Boston, MA, U.S. June 3 , 2021 \u2013 Zealand Pharma A\/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, today announced that members of its senior management team are scheduled to participate virtually in the Goldman Sachs 42nd Annual Global Healthcare Conference: Goldman Sachs 42nd Annual Global Healthcare Conference Date: Thursday, June 10, 2021 Presentation: 9:40 a.m. ET \/ 3:40 p.m. CET A live webcast of the event will be available on the &#8220;Events &amp; Presentations&#8221; page in the Investor section of the &hellip; Continue reading &quot;Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-03T20:13:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUwODY0MSM0MDA5NjA3MTMjMjAwMTcwMQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference\",\"datePublished\":\"2021-06-03T20:13:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\\\/\"},\"wordCount\":329,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDUwODY0MSM0MDA5NjA3MTMjMjAwMTcwMQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\\\/\",\"name\":\"Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDUwODY0MSM0MDA5NjA3MTMjMjAwMTcwMQ==\",\"datePublished\":\"2021-06-03T20:13:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDUwODY0MSM0MDA5NjA3MTMjMjAwMTcwMQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDUwODY0MSM0MDA5NjA3MTMjMjAwMTcwMQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference - Market Newsdesk","og_description":"C ompany a nnouncement \u2013 No. 36 \/ 202 1 Zealand Pharma to P articipate in Goldman Sachs 42 nd Annual Global Healthcare Conference Copenhagen, DK and Boston, MA, U.S. June 3 , 2021 \u2013 Zealand Pharma A\/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, today announced that members of its senior management team are scheduled to participate virtually in the Goldman Sachs 42nd Annual Global Healthcare Conference: Goldman Sachs 42nd Annual Global Healthcare Conference Date: Thursday, June 10, 2021 Presentation: 9:40 a.m. ET \/ 3:40 p.m. CET A live webcast of the event will be available on the &#8220;Events &amp; Presentations&#8221; page in the Investor section of the &hellip; Continue reading \"Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-03T20:13:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUwODY0MSM0MDA5NjA3MTMjMjAwMTcwMQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference","datePublished":"2021-06-03T20:13:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\/"},"wordCount":329,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUwODY0MSM0MDA5NjA3MTMjMjAwMTcwMQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\/","name":"Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUwODY0MSM0MDA5NjA3MTMjMjAwMTcwMQ==","datePublished":"2021-06-03T20:13:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUwODY0MSM0MDA5NjA3MTMjMjAwMTcwMQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDUwODY0MSM0MDA5NjA3MTMjMjAwMTcwMQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zealand-pharma-to-participate-in-goldman-sachs-42nd-annual-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/500651","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=500651"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/500651\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=500651"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=500651"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=500651"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}